Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biomerica (NASDAQ: BMRA ) stock is surging higher on Friday thanks to a new deal with Walmart (NYSE: WMT ) concerning its EZ Detect product. Source: Jonathan Weiss / Shutterstock.com A news release from...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! The final day of the workweek is here and with it comes a look at the pre-market stock movers for Friday! Source: Shutterstock Moving shares today are BTC prices rising, a reverse stock split...
Simple 2 minute at-home test detects early warning sign of colorectal cancer IRVINE, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that it has entered into a General Merchandise Supplier Agreement with Wa...
Gainers: Corvus Pharmaceuticals (NASDAQ:CRVS) +73%, Innate Pharma IPHA +51%, SmileDirectClub (NASDAQ:SDC) +12%, Biomerica (NASDAQ:BMRA) +9%, I-Mab (NASDAQ:IMAB) +6%. Losers: Protagonist Therapeutics PTGX -62%, TCR2 Therapeutics TCRR -31%,...
Biomerica recently reported its fiscal 2021 Q4 results highlighted by key product updates supporting a positive long-term outlook. The company's irritable bowel syndrome "IBS" diagnostic therapy technology platform continues to move towards an FDA approval representing a significant g...
Final patients to compete this double blinded trial by end of October. Top-Line trial results expected by year end. The InFoods ® IBS Diagnostic-Guided Therapy is the first therapy of its kind for treating all forms of IBS. InFoods ® IBS product...
Revenues increase 7.6% for fiscal 2021 vs fiscal 2020. InFoods ® IBS Endpoint Trial expected to be fully enrolled in less than 2 weeks. Biomerica receives multiple notices of allowance for patents covering the InFoods® Technology Platform provid...
Hundreds of millions of people worldwide suffer from depression IRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today that the Japanese Patent Office has issued a notice of allowance for Biomerica’s first patent pertaining to a ...
Digital Health Advertising and Social Media Campaigns launching alongside new site Currently in discussion with major retailers to increase distribution of EZ Detect™ Colon Disease Test IRVINE, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ...
RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13 th - 15 th , 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meeti...
News, Short Squeeze, Breakout and More Instantly...
inFoods ® IBS patients can now conveniently self-collect a blood sample using a simple finger-stick methodology in the privacy of their home inFoods ® IBS test is the first of its kind to identify specific foods that can trigger an Irritable Bowel Syndrome (I...
Biomerica (NASDAQ: BMRA) , a biomedical technology company that develops, patents, manufactures and markets advanced diagnostics and therapeutic products, has entered into an at-market issuance sales agreement with EF Hutton LLC and R.F. Lafferty & Co. Inc. According to the company, the agree...
With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th most common diagnosis by all physicians, IBS represents a significant healthcare burden. inF...